POSB345 Updated 2018 - 2020 Review of Patient-Reported Outcomes in Orphan Drug Labels Approved by the US Food and Drug Administration

Abstract

Authors

E Brown Hajdukova A Girardi E Rzepa K Scippa K Rudell

Full Text Cite This Article
Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×